Which has preferable valuation and earnings, AIMDW or CELUW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ainos $18.11K N/A N/A N/A N/A Celularity $26.55M N/A N/A N/A N/A

Is AIMDW or CELUW more profitable?

Company Net Margins Return on Equity Return on Assets Ainos N/A N/A N/A Celularity N/A N/A N/A

Does the media prefer AIMDW or CELUW?

In the previous week, Ainos and Ainos both had 2 articles in the media. Celularity's average media sentiment score of 0.76 beat Ainos' score of 0.62 indicating that Celularity is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ainos 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Celularity 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings & valuation, CELUW or ALVOW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Celularity $26.55M N/A N/A N/A N/A Alvotech $586.32M N/A N/A N/A N/A

Is CELUW or ALVOW more profitable?

Company Net Margins Return on Equity Return on Assets Celularity N/A N/A N/A Alvotech N/A N/A N/A

Which has preferable earnings & valuation, CELUW or ARAV?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Celularity $26.55M N/A N/A N/A N/A Aravive N/A N/A N/A -$0.90 N/A

Is CELUW or ARAV more profitable?

Company Net Margins Return on Equity Return on Assets Celularity N/A N/A N/A Aravive N/A N/A N/A

Which has better valuation & earnings, CELUW or ACABW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Celularity $26.55M N/A N/A N/A N/A Atlantic Coastal Acquisition Corp. II N/A N/A N/A N/A N/A

Is CELUW or ACABW more profitable?

Company Net Margins Return on Equity Return on Assets Celularity N/A N/A N/A Atlantic Coastal Acquisition Corp. II N/A N/A N/A

Which has higher earnings & valuation, CELUW or BFRIW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Celularity $26.55M N/A N/A N/A N/A Biofrontera $43.20M N/A N/A N/A N/A

Is CELUW or BFRIW more profitable?

Company Net Margins Return on Equity Return on Assets Celularity N/A N/A N/A Biofrontera N/A N/A N/A

Celularity (CELUW) Competitors

$0.0061 0.00 (-6.92%)

As of 04:00 PM Eastern

Compare

CELUW vs. AIMDW, ALVOW, ARAV, ACABW, and BFRIW

Should you buy Celularity stock or one of its competitors? MarketBeat compares Celularity with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Celularity include Ainos (AIMDW), Alvotech (ALVOW), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), and Biofrontera (BFRIW). These companies are all part of the "pharmaceutical products" industry.

How does Celularity compare to Ainos?

Ainos (NASDAQ:AIMDW) and Celularity (NASDAQ:CELUW) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, institutional ownership, valuation, dividends, earnings, media sentiment and profitability.

In the previous week, Ainos and Ainos both had 2 articles in the media. Celularity's average media sentiment score of 0.76 beat Ainos' score of 0.62 indicating that Celularity is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Ainos	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Celularity	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Company	Net Margins	Return on Equity	Return on Assets
Ainos	N/A	N/A	N/A
Celularity	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ainos	$18.11K	N/A	N/A	N/A	N/A
Celularity	$26.55M	N/A	N/A	N/A	N/A

Summary

Celularity beats Ainos on 2 of the 2 factors compared between the two stocks.

How does Celularity compare to Alvotech?

Celularity (NASDAQ:CELUW) and Alvotech (NASDAQ:ALVOW) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, dividends, profitability, earnings, risk, analyst recommendations, media sentiment and institutional ownership.

Company	Net Margins	Return on Equity	Return on Assets
Celularity	N/A	N/A	N/A
Alvotech	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Celularity	$26.55M	N/A	N/A	N/A	N/A
Alvotech	$586.32M	N/A	N/A	N/A	N/A

In the previous week, Celularity had 1 more articles in the media than Alvotech. MarketBeat recorded 2 mentions for Celularity and 1 mentions for Alvotech. Alvotech's average media sentiment score of 1.44 beat Celularity's score of 0.76 indicating that Alvotech is being referred to more favorably in the news media.

Company	Overall Sentiment
Celularity	Positive
Alvotech	Positive

Summary

Alvotech beats Celularity on 2 of the 3 factors compared between the two stocks.

How does Celularity compare to Aravive?

Celularity (NASDAQ:CELUW) and Aravive (NASDAQ:ARAV) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, valuation, media sentiment, risk, earnings, analyst recommendations, dividends and institutional ownership.

35.8% of Aravive shares are owned by institutional investors. 60.4% of Aravive shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, Celularity had 2 more articles in the media than Aravive. MarketBeat recorded 2 mentions for Celularity and 0 mentions for Aravive. Celularity's average media sentiment score of 0.76 beat Aravive's score of 0.00 indicating that Celularity is being referred to more favorably in the media.

Company	Overall Sentiment
Celularity	Positive
Aravive	Neutral

Company	Net Margins	Return on Equity	Return on Assets
Celularity	N/A	N/A	N/A
Aravive	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Celularity	$26.55M	N/A	N/A	N/A	N/A
Aravive	N/A	N/A	N/A	-$0.90	N/A

Summary

Celularity beats Aravive on 3 of the 5 factors compared between the two stocks.

How does Celularity compare to Atlantic Coastal Acquisition Corp. II?

Celularity (NASDAQ:CELUW) and Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) are both pharmaceutical products companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, media sentiment, earnings, analyst recommendations, institutional ownership, risk and valuation.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Celularity	$26.55M	N/A	N/A	N/A	N/A
Atlantic Coastal Acquisition Corp. II	N/A	N/A	N/A	N/A	N/A

In the previous week, Celularity had 2 more articles in the media than Atlantic Coastal Acquisition Corp. II. MarketBeat recorded 2 mentions for Celularity and 0 mentions for Atlantic Coastal Acquisition Corp. II. Celularity's average media sentiment score of 0.76 beat Atlantic Coastal Acquisition Corp. II's score of 0.00 indicating that Celularity is being referred to more favorably in the media.

Company	Overall Sentiment
Celularity	Positive
Atlantic Coastal Acquisition Corp. II	Neutral

Company	Net Margins	Return on Equity	Return on Assets
Celularity	N/A	N/A	N/A
Atlantic Coastal Acquisition Corp. II	N/A	N/A	N/A

Summary

Celularity beats Atlantic Coastal Acquisition Corp. II on 3 of the 3 factors compared between the two stocks.

How does Celularity compare to Biofrontera?

Celularity (NASDAQ:CELUW) and Biofrontera (NASDAQ:BFRIW) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, dividends, media sentiment, analyst recommendations, institutional ownership, earnings, risk and profitability.

In the previous week, Celularity had 1 more articles in the media than Biofrontera. MarketBeat recorded 2 mentions for Celularity and 1 mentions for Biofrontera. Celularity's average media sentiment score of 0.76 beat Biofrontera's score of 0.43 indicating that Celularity is being referred to more favorably in the media.

Company	Overall Sentiment
Celularity	Positive
Biofrontera	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Celularity	$26.55M	N/A	N/A	N/A	N/A
Biofrontera	$43.20M	N/A	N/A	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
Celularity	N/A	N/A	N/A
Biofrontera	N/A	N/A	N/A

Summary

Celularity beats Biofrontera on 2 of the 3 factors compared between the two stocks.

Get Celularity News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CELUW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CELUW vs. The Competition

Export

Metric	Celularity	Biotechnology Industry	Medical Sector	NASDAQ Exchange
Market Cap	N/A	$464.32M	$6.47B	$12.54B
Dividend Yield	N/A	3.87%	2.69%	5.22%
P/E Ratio	N/A	3.11	18.89	22.53
Price / Sales	N/A	6,509.16	520.79	112.26
Price / Cash	N/A	13.13	41.34	57.13
Price / Book	N/A	84.75	9.84	6.72
Net Income	N/A	-$96.07M	$3.57B	$337.19M
7 Day Performance	N/A	-0.06%	-1.16%	0.48%
1 Month Performance	N/A	0.75%	3.85%	5.07%
1 Year Performance	N/A	74.31%	27.40%	34.25%

Celularity Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CELUW Celularity	N/A	$0.01 -7.7%	N/A	-83.8%	$0.00	$26.55M	N/A	220	Gap Down
AIMDW Ainos	N/A	$0.06 -13.3%	N/A	-15.3%	$0.00	$18.11K	N/A	40	Gap Up
ALVOW Alvotech	N/A	$0.19 flat	N/A	-93.4%	$0.00	$586.32M	N/A	4	Short Interest Decrease Gap Up
ARAV Aravive	N/A	$0.04 flat	N/A	N/A	$0.00	N/A	N/A	20	High Trading Volume
ACABW Atlantic Coastal Acquisition Corp. II	N/A	$0.00 flat	N/A	-86.1%	$0.00	N/A	N/A	15

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CELUW) was last updated on 6/3/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Celularity (CELUW) Competitors